BALCHEM CORPBCPC決算レポート
Balchem Corp is a global specialty chemicals and nutritional ingredients provider that develops, manufactures and distributes application-specific products for human nutrition, animal health, pharmaceutical and industrial end markets, serving customers across North America, Europe and Asia Pacific.
BCPC Q4 2025 Key Financial Metrics
売上高
$263.6M
粗利益
$93.9M
営業利益
$52.3M
純利益
$39.2M
粗利益率
35.6%
営業利益率
19.8%
純利益率
14.9%
前年比成長
9.8%
EPS
$1.21
資金フロー
BALCHEM CORP Q4 2025 財務サマリー
BALCHEM CORP reported revenue of $263.6M (up 9.8% YoY) for Q4 2025, with a net profit of $39.2M (up 16.8% YoY) (14.9% margin). Cost of goods sold was $169.7M, operating expenses totaled $41.6M.
主要財務指標
| 総売上高 | $263.6M |
|---|---|
| 純利益 | $39.2M |
| 粗利益率 | 35.6% |
| 営業利益率 | 19.8% |
| 報告期間 | Q4 2025 |
売上内訳
BALCHEM CORP Q4 2025 revenue of $263.6M breaks down across 3 segments, led by Human Nutrition And Health at $166.1M (63.0% of total).
| セグメント | 売上高 | 構成比 |
|---|---|---|
| Human Nutrition And Health | $166.1M | 63.0% |
| Animal Nutrition And Health | $61.2M | 23.2% |
| Specialty Products | $34.8M | 13.2% |
BALCHEM CORP セグメント別売上 — 四半期推移
BALCHEM CORP revenue by segment across the last 4 reported quarters, showing how each business line (such as Human Nutrition And Health and Animal Nutrition And Health) has evolved quarter over quarter.
| セグメント | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|
| Human Nutrition And Health | $166.1M | $174.1M | $160.8M | $158.5M |
| Animal Nutrition And Health | $61.2M | $56.4M | $56.0M | $57.3M |
| Specialty Products | $34.8M | $35.7M | $37.2M | $33.3M |
BALCHEM CORP 年度売上推移
BALCHEM CORP annual revenue history includes year-by-year totals (for example, 2025 revenue was $1.0B). Click any linked year to see what changed vs the prior 10-K.
BALCHEM CORP 四半期売上・純利益の履歴
BALCHEM CORP quarterly results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| 四半期 | 売上高 | 売上前年比 | 純利益 | 純利益率 |
|---|---|---|---|---|
| Q4 2025 | $263.6M | +9.8% | $39.2M | 14.9% |
| Q3 2025 | $267.6M | +11.5% | $40.3M | 15.1% |
| Q2 2025 | $255.5M | +9.1% | $38.3M | 15.0% |
| Q1 2025 | $250.5M | +4.5% | $37.1M | 14.8% |
| Q4 2024 | $240.0M | +4.9% | $33.6M | 14.0% |
| Q3 2024 | $239.9M | +4.3% | $33.8M | 14.1% |
| Q2 2024 | $234.1M | +1.2% | $32.1M | 13.7% |
| Q1 2024 | $239.7M | +3.1% | $29.0M | 12.1% |
損益計算書
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| 売上高 | $239.7M | $234.1M | $239.9M | $240.0M | $250.5M | $255.5M | $267.6M | $263.6M |
| 前年比成長 | 3.1% | 1.2% | 4.3% | 4.9% | 4.5% | 9.1% | 11.5% | 9.8% |
貸借対照表
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| 総資産 | $1.59B | $1.57B | $1.60B | $1.58B | $1.62B | $1.68B | $1.66B | $1.69B |
| 総負債 | $509.9M | $462.6M | $419.7M | $425.5M | $408.9M | $410.3M | $363.2M | $428.8M |
| 株主資本 | $1.08B | $1.11B | $1.18B | $1.15B | $1.21B | $1.27B | $1.30B | $1.26B |
キャッシュフロー
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| 営業CF | $33.4M | $45.0M | $51.3M | $52.3M | $36.5M | $47.3M | $65.6M | $67.3M |